Cart
sales@molnova.com
Beta-Hydroxyisovaleric acid
CAS No. 625-08-1
Beta-Hydroxyisovaleric acid( —— )
Catalog No. M15365 CAS No. 625-08-1
Used as pharmaceutical intermediates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | 52 | In Stock |
|
Biological Information
-
Product NameBeta-Hydroxyisovaleric acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionUsed as pharmaceutical intermediates.
-
DescriptionUsed as pharmaceutical intermediates.
-
In VitroThe reduced activity of methylcrotonyl-CoA carboxylase (MCC) leads to an elevated excretion of 3-methylcrotonic acid, the product of its hydration (3-hydroxyisovaleric acid: 3-HIA), and 3-methylcrotonylglycine, formed by conjugation with glycine.
-
In VivoIn male mice (ICR/Jcl) at 8 weeks of age fed the biotin-deficient diet for 6 weeks, the concentration of urinary 3-Hydroxyisovaleric acid is 114.2 mM creatinine, which is higher than the concentration of 35.2 mM creatinine in mice fed the biotin-deficient diet for 4 weeks.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number625-08-1
-
Formula Weight118.13
-
Molecular FormulaC5H10O3
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESCC(C)(O)CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sabourin PJ, Bieber LL. Arch Biochem Biophys. 1981 Jan;206(1):132-44.
molnova catalog
related products
-
Oseltamivir acid met...
Oseltamivir acid methyl ester hydrochloride is a precursor form of oseltamivir acid. Oseltamivir acid methyl ester is converted to oseltamivir acid converted by carboxylesterase 1 (CES1).
-
CMF019
CMF019 is a potent agonist of the Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ (pKis: 8.58, 8.49, and 8.71 for the human, rat, and mouse).
-
Pomalidomide-C4-COOH
Pomalidomide-C4-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
